Sonendo Dividendi e riacquisti

Dividendo criteri di controllo 0/6

Sonendo non ha registrato alcun pagamento di dividendi.

Informazioni chiave

n/a

Rendimento del dividendo

-0.6%

Rendimento del riacquisto

Rendimento totale per gli azionisti	-0.6%
Rendimento futuro dei dividendi	0%
Crescita dei dividendi	n/a
Prossima data di pagamento dei dividendi	n/a
Data di stacco del dividendo	n/a
Dividendo per azione	n/a
Rapporto di remunerazione	n/a

Aggiornamenti recenti su dividendi e riacquisti

Nessun aggiornamento

Recent updates

Stabilità e crescita dei pagamenti

Recupero dei dati sui dividendi

Dividendo stabile: Dati insufficienti per determinare se i dividendi per azione di SONX.D siano rimasti stabili in passato.

Dividendo in crescita: Dati insufficienti per determinare se i pagamenti dei dividendi di SONX.D siano aumentati.

Rendimento dei dividendi rispetto al mercato

Sonendo Rendimento dei dividendi rispetto al mercato

Come si colloca il rendimento da dividendo di SONX.D rispetto al mercato?
Segmento	Rendimento dei dividendi
Azienda (SONX.D)	n/a
Fondo del 25% del mercato (US)	1.4%
Top 25% del mercato (US)	4.3%
Media del settore (Medical Equipment)	1.6%
Analista previsionale (SONX.D) (fino a 3 anni)	0%

Dividendo notevole: Impossibile valutare il rendimento dei dividendi di SONX.D rispetto al 25% inferiore dei pagatori di dividendi, poiché la società non ha segnalato alcun pagamento recente.

Dividendo elevato: Impossibile valutare il rendimento dei dividendi di SONX.D rispetto al 25% dei maggiori pagatori di dividendi, poiché la società non ha segnalato alcun pagamento recente.

Distribuzione degli utili agli azionisti

Copertura degli utili: Dati insufficienti per calcolare il payout ratio di SONX.D per determinare se i suoi pagamenti di dividendi sono coperti dagli utili.

Pagamenti in contanti agli azionisti

Copertura del flusso di cassa: Impossibile calcolare la sostenibilità dei dividendi poiché SONX.D non ha segnalato alcun pagamento.

Sonendo Dividendi e riacquisti

Dividendo criteri di controllo 0/6

Informazioni chiave

Aggiornamenti recenti su dividendi e riacquisti

Recent updates

Sonendo, Inc. Launches ProControl for the G4 System

Sonendo, Inc. Revises Guidance for the Fiscal Year 2024

Sonendo, Inc. Announces Impairment of Long-Lived Assets for the Three Months Ended June 30, 2024

Sonendo, Inc. to Report Q2, 2024 Results on Aug 07, 2024

Sonendo, Inc. Announces the Appointment of John Bostjancic as Chief Financial Officer

Sonendo, Inc. Raises Revenue Guidance for the Full Year of 2024

Sonendo, Inc., Annual General Meeting, Jun 10, 2024

Sonendo, Inc. to Report Q1, 2024 Results on May 08, 2024

NYSE Intends to Apply to SEC for Delisting of the Sonendo's Common Stock

Sonendo, Inc. Announces Impairment of Long-Lived Assets for the Three Months Ended December 31, 2023

Sonendo, Inc. Announces Impairment of Long-Lived Assets for the Three Months Ended December 31, 2023

Sonendo, Inc. Announces CFO Changes

Sonendo, Inc. Announces CFO Changes

Valsoft Corporation Inc. acquired Dog Breath Software, Inc. from Sonendo, Inc. (OTCPK:SONX) for approximately $16 million.

Valsoft Corporation Inc. acquired Dog Breath Software, Inc. from Sonendo, Inc. (OTCPK:SONX) for approximately $16 million.

Sonendo, Inc. to Report Fiscal Year 2023 Results on Mar 11, 2024

Sonendo, Inc. Announces Resignation of Karen Mcginnis as Director and Member of the Audit Committee and Compensation Committee, Effective March 31, 2024

Sonendo Announces Suspension of NYSE Trading, to Commence Trading on the OTCQX Effective November 22, 2023

Sonendo, Inc. Announces Resignation of Michael Smith as Chief Commercial Officer Effective December 1, 2023

Price target decreased by 14% to US$1.67

Analysts Have Just Cut Their Sonendo, Inc. (NYSE:SONX) Revenue Estimates By 18%

Third quarter 2023 earnings: EPS misses analyst expectations

Sonendo, Inc. to Report Q3, 2023 Results on Nov 08, 2023

Sonendo, Inc. Provides Revenue Guidance for the Third Quarter and Full Year 2023

Sonendo, Inc. Announces Receipt of Notice of Non-Compliance with NYSE Trading Share Price Listing Rule

Sonendo, Inc. Announces Launch of Second Generation CleanFlow Procedure Instrument for Heightened Efficacy and Ease of Use

Price target decreased by 15% to US$2.65

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Sonendo, Inc. Provides Revenue Guidance for the Third Quarter and Full Year of 2023

Sonendo, Inc.'s Enhanced CleanFlow Procedure Instrument Now Indicated for Use on Anterior Teeth

Price target decreased by 7.5% to US$3.10

Sonendo, Inc. Announces the Publication of New Study That Found the GentleWave System to Be Significantly More Effective Than Conventional Irrigation Methods at Dissolving TissueDissolution During Root Canal Procedures

New minor risk - Insider selling

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Sonendo, Inc. Provides Revenue Guidance for the Second Quarter and Full Year of 2023

A Piece Of The Puzzle Missing From Sonendo, Inc.'s (NYSE:SONX) Share Price

Insider recently bought US$80k worth of stock

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Sonendo, Inc. to Report Q4, 2022 Results on Mar 08, 2023

Sonendo unit PIPStek files patent infringement lawsuit against Biolase

Insider recently bought US$56k worth of stock

Price target decreased to US$3.67

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Sonendo, Inc. Provides Revenue Guidance for the Year 2022

GAAP EPS of -$0.47 misses by $0.08, revenue of $9.8M beats by $0.49M

Sonendo Announces Health Canada Regulatory Approval for Next Generation GentleWave G4 System

Sonendo, Inc. to Report Q3, 2022 Results on Nov 09, 2022

Sonendo® Announces Release of GentleWave® G4 System

Consensus forecasts updated

Sonendo, Inc. announced that it has received $62.999997 million in funding from ArrowMark Colorado Holdings, LLC

Sonendo, Inc. announced that it expects to receive $62.999997 million in funding from ArrowMark Colorado Holdings, LLC

Sonendo announces $63 million private placement

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Sonendo, Inc. Expects Revenue Guidance for Full Year 2022

Sonendo, Inc. to Report Q2, 2022 Results on Aug 10, 2022

President recently bought US$64k worth of stock

Sonendo, Inc. Announces Executive Management Team Changes

Insider recently bought US$133k worth of stock

Sonendo, Inc. Provides Revenue Guidance for the Year 2022

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Sonendo Announces Launch of Cleanflow™ Technology to Improve Doctor and Patient Experience

Sonendo, Inc. to Report Q1, 2022 Results on May 10, 2022

Cory A. Eaves and Paul S. Madera Not to Stand for Re-Election as Directors of Sonendo, Inc

Sonendo, Inc. to Report Q4, 2021 Results on Mar 23, 2022

Sonendo, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year 2021

Third quarter 2021 earnings: EPS and revenues exceed analyst expectations

Sonendo: Painful Debut For This Dental Play

Less than half of directors are independent

Stabilità e crescita dei pagamenti

Rendimento dei dividendi rispetto al mercato

Distribuzione degli utili agli azionisti

Pagamenti in contanti agli azionisti

Scoprire le società che pagano dividendi forti